Work

Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer

Year: 2024

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-024-07337-3

Authors: Claire Sathe, Melissa K. Accordino, David DeStephano, Mansi Shah, Jason D. Wright, Dawn L. Hershman

Institutions: Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Columbia University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: green

Funders: American Cancer Society, Breast Cancer Research Foundation, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W4396638483

FWCI: 0.765

Cites: 15

Cited by: 3

Related to: 10